Carlsmed Inc. (CARL)
NASDAQ
Closed
Sep 17, 2026
Day's Range
15.1352 wk Range
8.50Overview - CARL - Carlsmed Inc.
Key Statistics
Valuation
Enterprise Value
377.45M
P/E (Trailing)
‪-7.30‬
P/E (Forward)
‪-11.83‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪7.04‬
Price / Book
‪5.27‬
EV / EBITDA
‪-9.86‬
Profitability
Gross Margin
‪76.77%‬
Profit Margin
‪-57.42%‬
Operating Margin
‪-58.26%‬
Return on Assets
‪-28.18%‬
Return on Equity
‪-66.14%‬
Ownership
Shares Outstanding
27.26M
Float
15.66M
Short % of Shares Outstanding
‪12.87%‬
Held by Insiders
‪44.42%‬
Held by Institutions
‪40.37%‬
Price stats
50-Day Avg
‪12.94‬
200-Day Avg
‪12.07‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 19.20‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CARL - Carlsmed Inc.
Peers - CARL - Carlsmed Inc.
Peer Comparison
Compared with companies in Health Information Services listed on NASDAQ.
Profile Summary - CARL - Carlsmed Inc.
About
Carlsmed, Inc. is a commercial-stage medical technology company founded in 2018 and headquartered in Carlsbad, California. It specializes in AI-enabled personalized spine surgery solutions, aiming to enhance patient outcomes and reduce healthcare costs in spine fusion procedures. The company's core offering, the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
